News

Aetna, Elevance Health and Kaiser Permanente will cover Wegovy to reduce heart attack risk in Medicare patients with heart conditions, following the FDA's approval of the drug to reduce stroke or heart attack risk in March.

Senator Bernie Sanders, who cites a Yale study that found an Ozempic dose costs Novo Nordisk less than $5 a month to manufacture, wants to meet with the drugmaker's CEO to discuss the drug's costs.

Larry Krasner, Philadelphia's district attorney, filed a lawsuit against Eli Lilly, Novo Nordisk and other drugmakers and pharmacy benefit managers, on behalf of the 1.1 million Pennsylvanians who have diabetes, like himself.

Last fall, the Biden administration issued an executive order giving the Department of Health and Human Services the daunting task of putting guardrails around increasingly advanced artificial intelligence health care models.

The Washington Saves program, which will take effect in 2027, was signed into law late last week, and will require certain employers that do not offer a retirement plan to enroll employees into the state-run auto-IRA program.

Organizational culture and the tone set by senior leadership affect how both employer-driven and employee-driven flexibility evolve.

With one estimate predicting women will account for close to half of the disease costs in the U.S. by 2040 – a $66 billion price tag – it's a high-priority topic for the Biden administration and HHS, which will soon release guidelines.

Optum, which already has more than 90,000 employed or affiliated physicians, has agreed to purchase Steward Health Care's struggling physician group, which includes primary care in addition to a physician contracting network.